1.      Adamo MP, Zapata M, Frey TK. Analysis of gene expression in fetal and adult cells infected with rubella virus. Virology. 2008;370(1):1-11. doi:10.1016/j.virol.2007.08.003

2.      Adamo P, Asís L, Silveyra P, et al. Rubella virus does not induce apoptosis in primary human embryo fibroblast cultures: a possible way of viral persistence in congenital infection. Viral Immunol. 2004;17(1):87-100. doi:10.1089/088282404322875485

3.      American Academy of Pediatrics. Cytomegalovirus infection. In: Red Book: 2024-2027 Report of the Committee on Infectious Diseases, 33rd Ed, Kimberlin DW, Banerjee R, Barnett ED, Lynfield R, Sawyer MH, (Eds), American Academy of Pediatrics, Itasca, IL 2024. p.344.

4.      American Academy of Pediatrics. Herpes simplex. In: Red Book: 2024-2027 Report of the Committee on Infectious Diseases, 33rd ed, Kimberlin DW, Banerjee R, Barnett ED, Lynfield R, Sawyer MH (Eds), American Academy of Pediatrics, Itasca, IL 2024. p.467.

5.      American Academy of Pediatrics. Rubella. In: Red Book: 2018 Report of the Committee on Infectious Diseases, 31st ed, Kimberlin DW, Brady MT, Jackson MA, Long SS (Eds), American Academy of Pediatrics, Itasca, IL 2018. p.705.

6.      American Academy of Pediatrics. Varicella-Zoster Infections. In: Red Book: 2024-2027 Report of the Committee on Infectious Diseases, 33, Kimberlin DW, Banerjee R, Barnett ED, et al (Eds), American Academy of Pediatrics, Itasca, IL 2024.

7.      Bouthry E, Portet-Sulla V, Bouokazi MM, et al. Neonatal herpes: case series in two obstetric centres over a 10-year period (2013-2023), France. Eur J Pediatr. 2024;183(8):3183-3191. doi:10.1007/s00431-024-05581-9

8.      Caviness AC, Demmler GJ, Selwyn BJ. Clinical and laboratory features of neonatal herpes simplex virus infection: a case-control study. Pediatr Infect Dis J. 2008;27(5):425-430. doi:10.1097/INF.0b013e3181646d95

9.      Centers for Disease Control and Prevention (CDC). Morbidity and Mortality Weekly Report. Updated recommendations for Use of VariZIG-United States, 2013. http://www.cdc.gov/mmwr/preview/mmwrhtml/mm6228a4.htm (Accessed on July 23, 2013).

10.  Centers for Disease Control and Prevention (CDC). Progress toward elimination of rubella and congenital rubella syndrome--the Americas, 2003-2008. MMWR Morb Mortal Wkly Rep. 2008;57(43):1176-1179.

11.  Control and prevention of rubella: evaluation and management of suspected outbreaks, rubella in pregnant women, and surveillance for congenital rubella syndrome. MMWR Recomm Rep. 2001;50(RR-12):1-23.

12.  Corey L, Wald A. Maternal and neonatal herpes simplex virus infections. N Engl J Med. 2009;361(14):1376-1385. doi:10.1056/NEJMra0807633

13.  Costello A, Dua T, Duran P, et al. Defining the syndrome associated with congenital Zika virus infection. Bull World Health Organ. 2016;94(6):406-406A. doi:10.2471/BLT.16.176990

14.  Donda K, Sharma M, Amponsah JK, et al. Trends in the incidence, mortality, and cost of neonatal herpes simplex virus hospitalizations in the United States from 2003 to 2014. J Perinatol. 2019;39(5):697-707. doi:10.1038/s41372-019-0352-7

15.  Duncan R, Muller J, Lee N, et al. Rubella virus-induced apoptosis varies among cell lines and is modulated by Bcl-XL and caspase inhibitors. Virology. 1999;255(1):117-128. doi:10.1006/viro.1998.9562

16.  Durrheim DN, Andrus JK, Tabassum S, et al. Accelerating Global Measles and Rubella Eradication-Saving Millions of Lives, Preventing Disability, and Averting the Next Pandemic. Vaccines (Basel). 2024;12(6):699. doi:10.3390/vaccines12060699

17.  Flagg EW, Weinstock H. Incidence of neonatal herpes simplex virus infections in the United States, 2006. Pediatrics. 2011;127(1): e1-e8. doi:10.1542/peds.2010-0134

18.  Goderis J, De Leenheer E, Smets K, et al. Hearing loss and congenital CMV infection: a systematic review. Pediatrics. 2014;134(5):972-982. doi:10.1542/peds.2014-1173

19.  Guerina NG, Hsu HW, Meissner HC, et al. Neonatal serologic screening and early treatment for congenital Toxoplasma gondii infection. The New England Regional Toxoplasma Working Group. N Engl J Med. 1994;330(26):1858-1863. doi:10.1056/NEJM199406303302604

20.  Harrison GJ. Cytomegalovirus. In: Feigin and Cherry's Textbook of Pediatric Infectious Diseases, 8th ed, Cherry JD, Harrison GJ, Kaplan SL, et al (Eds), Elsevier Saunders, Philadelphia 2019. p.1429.

21.  Istas AS, Demmler GJ, Dobbins JG, et al. Surveillance for congenital cytomegalovirus disease: a report from the National Congenital Cytomegalovirus Disease Registry. Clin Infect Dis. 1995;20(3):665-670. doi:10.1093/clinids/20.3.665

22.  Kenneson A, Cannon MJ. Review and meta-analysis of the epidemiology of congenital cytomegalovirus (CMV) infection. Rev Med Virol. 2007;17(4):253-276. doi:10.1002/rmv.535

23.  Kidszun A, Bruns A, Schreiner D, et al. Characteristics of neonatal herpes simplex virus infections in Germany: results of a 2-year prospective nationwide surveillance study. Arch Dis Child Fetal Neonatal Ed. 2022;107(2):188-192. doi:10.1136/archdischild-2021-321940

24.  Lao S, Flagg EW, Schillinger JA. Incidence and Characteristics of Neonatal Herpes: Comparison of Two Population-Based Data Sources, New York City, 2006-2015. Sex Transm Dis. 2019;46(2):125-131. doi:10.1097/OLQ.0000000000000923

25.  Mahnert N, Roberts SW, Laibl VR, et al. The incidence of neonatal herpes infection. Am J Obstet Gynecol. 2007;196(5): e55-e56. doi:10.1016/j.ajog.2006.10.911

26.  Maldonado YA, Read JS; COMMITTEE ON INFECTIOUS DISEASES. Diagnosis, Treatment, and Prevention of Congenital Toxoplasmosis in the United States. Pediatrics. 2017;139(2): e20163860. doi:10.1542/peds.2016-3860

27.  Malik AN, Hildebrand GD, Sekhri R, et al. Bilateral macular scars following intrauterine herpes simplex virus type 2 infection. J AAPOS. 2008;12(3):305-306. doi:10.1016/j.jaapos.2008.01.002

28.  Marquez L, Levy ML, Munoz FM, et al. A report of three cases and review of intrauterine herpes simplex virus infection. Pediatr Infect Dis J. 2011;30(2):153-157. doi:10.1097/INF.0b013e3181f55a5c

29.  McAuley J, Boyer KM, Patel D, et al. Early and longitudinal evaluations of treated infants and children and untreated historical patients with congenital toxoplasmosis: the Chicago Collaborative Treatment Trial. Clin Infect Dis. 1994;18(1):38-72. doi:10.1093/clinids/18.1.38

30.  McIntosh ED, Menser MA. A fifty-year follow-up of congenital rubella. Lancet. 1992;340(8816):414-415. doi:10.1016/0140-6736(92)91483-o

31.  Melvin AJ, Mohan KM, Schiffer JT, et al. Plasma and cerebrospinal fluid herpes simplex virus levels at diagnosis and outcome of neonatal infection. J Pediatr. 2015;166(4):827-833. doi:10.1016/j.jpeds.2014.11.011

32.  Melvin AJ, Mohan KM, Vora SB, et al. Neonatal Herpes Simplex Virus Infection: Epidemiology and Outcomes in the Modern Era. J Pediatric Infect Dis Soc. 2022;11(3):94-101. doi:10.1093/jpids/piab105

33.  Miner JJ, Cao B, Govero J, et al. Zika Virus Infection during Pregnancy in Mice Causes Placental Damage and Fetal Demise. Cell. 2016;165(5):1081-1091. doi:10.1016/j.cell.2016.05.008

34.  Mizrahi EM, Tharp BR. A characteristic EEG pattern in neonatal herpes simplex encephalitis. Neurology. 1982;32(11):1215-1220. doi:10.1212/wnl.32.11.1215

35.  Mukhopadhyay S, Itell HL, Hartman E, et al. Breast Milk and Saliva for Postnatal Cyto†megalovirus Screening among Very Low Birth Weight Infants. Pediatr Infect Dis J. 2022;41(11):904-910. doi:10.1097/INF.0000000000003671

36.  National Notifiable Diseases Surveillance System (NNDSS) Congenital Cytomegalovirus (cCMV) Infection and Disease 2024 Case Definitions. [Accessed on March 31, 2025] Available from: https://ndc.services.cdc.gov/case-definitions/congenital-cytomegalovirus-ccmv-infection-and-disease-2024/.

37.  Neu N, Duchon J, Zachariah P. TORCH infections. Clin Perinatol. 2015;42(1):77-viii. doi:10.1016/j.clp.2014.11.001

38.  Pass RF, Hutto C, Ricks R, et al. Increased rate of cytomegalovirus infection among parents of children attending day-care centers. N Engl J Med. 1986;314(22):1414-1418. doi:10.1056/NEJM198605293142204

39.  Peyron F, L'ollivier C, Mandelbrot L, et al. Maternal and Congenital Toxoplasmosis: Diagnosis and Treatment Recommendations of a French Multidisciplinary Working Group. Pathogens. 2019;8(1):24. doi:10.3390/pathogens8010024

40.  Picone O, Vauloup-Fellous C, Cordier AG, et al. A series of 238 cytomegalovirus primary infections during pregnancy: description and outcome. Prenat Diagn.2013;33(8):751-758. doi:10.1002/pd.4118

41.  Pittet LF, Curtis N. Postnatal Exposure to Herpes Simplex Virus: To Treat or Not to Treat? Pediatr Infect Dis J. 2021;40(5S): S16-S21. doi:10.1097/INF.0000000000002846

42.  Plotkin, SA, Reef SE, Cooper LZ et al. Rubella. In: Infectious Diseases of the Fetus and Newborn Infant, 7th ed, Remington, JS, Klein, JO, Wilson, CB, et al (Eds), Elsevier Saunders, Philadelphia 2011. p.861.

43.  Reina J, Saurina J, Fernandez-Baca V, et al. Evaluation of a direct immunofluorescence cytospin assay for the detection of herpes simplex virus in clinical samples. Eur J Clin Microbiol Infect Dis. 1997;16(11):851-854. doi:10.1007/BF01700419

44.  Remington JS, McLeod R, Thulliez P, et al. Toxoplasmosis. In: Infectious Disease of the Fetus and Newborn Infant, 6th ed, Remington JS, Klein J, Wilson CB, Baker CJ (Eds), Elsevier Saunders, Philadelphia 2006. p.947.

45.  Rico-Torres CP, Vargas-Villavicencio JA, et al. Is Toxoplasma gondii type related to clinical outcome in human congenital infection? Systematic and critical review. Eur J Clin Microbiol Infect Dis. 2016;35(7):1079-1088. doi:10.1007/s10096-016-2656-2

46.  Ross SA, Michaels MG, Ahmed A, et al. Contribution of Breastfeeding to False-Positive Saliva Polymerase Chain Reaction for Newborn Congenital Cytomegalovirus Screening. J Infect Dis. 2018;217(10):1612-1615. doi:10.1093/infdis/jiy057

47.  Sampath V, Narendran V, Donovan EF, et al. Nonimmune hydrops fetalis and fulminant fatal disease due to congenital cytomegalovirus infection in a premature infant. J Perinatol. 2005;25(9):608-611. doi:10.1038/sj.jp.7211357

48.  SYROCOT (Systematic Review on Congenital Toxoplasmosis) study group, Thiébaut R, Leproust S, et al. Effectiveness of prenatal treatment for congenital toxoplasmosis: a meta-analysis of individual patients' data. Lancet. 2007;369(9556):115-122. doi:10.1016/S0140-6736(07)60072-5

49.  Zimmerman LA, Knapp JK, Antoni S, et al. Progress Toward Rubella and Congenital Rubella Syndrome Control and Elimination- Worldwide, 2012-2020. MMWR Morb Mortal Wkly Rep. 2022;71(6):196-201. doi:10.15585/mmwr.mm7106a2